View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB36 Publication ID: Spring 2017 
Title: Amendments to the Drug Enforcement Administration Hearing Regulations 
Abstract:

This rule proposes to amend the Drug Enforcement Administration (DEA) hearing regulations. In this rule the DEA proposes to amend its regulations that govern the procedures in administrative hearings to deny, revoke or suspend a DEA registration to handle controlled substances or listed chemicals. These regulations have not been amended since the inception of the regulations in 1971.

 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1316   
Legal Authority: 21 U.S.C. 811    21 U.S.C. 812    21 U.S.C. 871(b)    21 U.S.C. 875    21 U.S.C. 958(d)    21 U.S.C. 965   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  To Be Determined 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Demetra Ashley
Associate Deputy Assistant Administrator
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7165